Market Trends Astellas Pharma Non-GAAP EPS of ¥124.60, revenue of ¥1453.03B; updates FY outlookBy admin8996erT0allFebruary 4, 2025 Astellas Pharma press release (OTCPK:ALPMF): Non-GAAP EPS of ¥124.60 for the first nine months of FY2024. Revenue of ¥1453.03B (+22.2% Y/Y). Core…
